hexamidine

N/A

Report date: 2025/04/24 16:17:38
NME

Base Information

Drug Namehexamidine
Drug Alias Namematripase inhibitors (Lombardi Cancer Center)
ClassificationSmall molecules
Mechanisms of ActionSerine protease inhibitors
TargetsSerine protease
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeorgetown University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeorgetown University Medical Center
Active IndicationsN/A
Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A